Sexuality After Treatment of Diffuse Large B-cell Lymphoma: Patients' Experiences and Psychometric Testing of the Sexual Adjustment Questionnaire-Swedish Version II.
Journal
Cancer nursing
ISSN: 1538-9804
Titre abrégé: Cancer Nurs
Pays: United States
ID NLM: 7805358
Informations de publication
Date de publication:
Historique:
pubmed:
18
8
2020
medline:
26
11
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Sexuality is an important part of health-related quality of life. To ensure adequate supportive interventions, valid and reliable instruments specific to sexual changes and adjustments after cancer treatment are needed. The aims of this study were to test the psychometric properties of the Sexual Adjustment Questionnaire-Swedish version II (SAQ-SII) in patients treated for diffuse large B-cell lymphoma and to describe and explore patients' experiences of sexuality after treatment. A cross-sectional study was conducted in 2019, using SAQ-SII and data from the National Quality Registry for Leukemia-subregistry for Lymphoma, which included 257 patients (25% response rate). An exploratory factor analysis was performed for psychometric evaluation. Internal consistency was assessed by Cronbach's α. Independent t tests, analysis of variance, and multiple regression were used to describe patients' experiences of sexuality. The exploratory factor analysis resulted in a 4-factor structure, explaining 65.7% of the total scale variance (SAQ-SII). The Cronbach's α for the SAQ-SII was 0.88 and varied between 0.70 and 0.89 across subscales. Sexuality was affected in various ways and extent. Sexual Interest was most affected, whereas Sexual Function was least affected. Being male, of younger age, without comorbidities, and in a relationship were associated to a higher Sexual Interest. The SAQ-SII is a valid and reliable instrument to measure changes and adjustments in sexuality in patients treated for lymphoma. Assessments of sexuality in a broad sense should be an integrated part of cancer care to ensure timely interventions for those who need and want support.
Sections du résumé
BACKGROUND
Sexuality is an important part of health-related quality of life. To ensure adequate supportive interventions, valid and reliable instruments specific to sexual changes and adjustments after cancer treatment are needed.
OBJECTIVES
The aims of this study were to test the psychometric properties of the Sexual Adjustment Questionnaire-Swedish version II (SAQ-SII) in patients treated for diffuse large B-cell lymphoma and to describe and explore patients' experiences of sexuality after treatment.
METHODS
A cross-sectional study was conducted in 2019, using SAQ-SII and data from the National Quality Registry for Leukemia-subregistry for Lymphoma, which included 257 patients (25% response rate). An exploratory factor analysis was performed for psychometric evaluation. Internal consistency was assessed by Cronbach's α. Independent t tests, analysis of variance, and multiple regression were used to describe patients' experiences of sexuality.
RESULTS
The exploratory factor analysis resulted in a 4-factor structure, explaining 65.7% of the total scale variance (SAQ-SII). The Cronbach's α for the SAQ-SII was 0.88 and varied between 0.70 and 0.89 across subscales. Sexuality was affected in various ways and extent. Sexual Interest was most affected, whereas Sexual Function was least affected. Being male, of younger age, without comorbidities, and in a relationship were associated to a higher Sexual Interest.
CONCLUSIONS
The SAQ-SII is a valid and reliable instrument to measure changes and adjustments in sexuality in patients treated for lymphoma.
IMPLICATIONS FOR PRACTICE
Assessments of sexuality in a broad sense should be an integrated part of cancer care to ensure timely interventions for those who need and want support.
Identifiants
pubmed: 32804757
pii: 00002820-202111000-00010
doi: 10.1097/NCC.0000000000000866
pmc: PMC8560151
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
499-508Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Sex Disabil. 2016;34(4):367-388
pubmed: 27881887
ANA Publ. 1979;(MS-10):i-ii, 1-14
pubmed: 254563
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Oncol Nurs Forum. 2011 Sep;38(5):E351-9
pubmed: 21875831
J Clin Nurs. 2013 Dec;22(23-24):3503-12
pubmed: 24003940
Bone Marrow Transplant. 2018 Aug;53(8):967-976
pubmed: 29403022
Clin J Oncol Nurs. 2007 Oct;11(5):671-5
pubmed: 17962175
J Med Internet Res. 2015 May 07;17(5):e111
pubmed: 25953059
Cancer Nurs. 2015 Mar-Apr;38(2):99-110
pubmed: 25692735
Eur J Oncol Nurs. 2011 Feb;15(1):38-45
pubmed: 20584629
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
J Med Internet Res. 2019 Mar 14;21(3):e10672
pubmed: 30869647
Curr Probl Cancer. 2013 Nov-Dec;37(6):319-52
pubmed: 24331239
Cancer. 2016 Dec 15;122(24):3883-3891
pubmed: 27531631
Semin Oncol Nurs. 2008 May;24(2):71-9
pubmed: 18442670
Ann Hematol. 2017 May;96(5):739-747
pubmed: 28184983
Bone Marrow Transplant. 2012 May;47(5):716-24
pubmed: 21874054
Ann Oncol. 2015 Apr;26(4):779-786
pubmed: 25623049
Oncol Nurs Forum. 1986 May-Jun;13(3):53-9
pubmed: 3635138
J Nurs Meas. 2014;22(2):241-54
pubmed: 25255676
J Clin Oncol. 2012 Oct 20;30(30):3712-9
pubmed: 23008322
Eur J Oncol Nurs. 2007 Sep;11(4):298-308
pubmed: 17196431
Oncol Nurs Forum. 2015 Sep;42(5):488-97
pubmed: 26302277
J Sex Med. 2011 Jul;8(7):1833-41
pubmed: 21324087
Br J Haematol. 2014 Feb;164(4):526-35
pubmed: 24236665